Communications Biology (Nov 2021)
Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer
Abstract
Gupta et al. demonstrate that targeting isoform-specific TGFβ leads to an increase in the anti-tumor response when compared to pan-TGFβ inhibition, due to enhanced CD8 T cell function. The authors also report that combining TGFβ inhibition with immune checkpoint blockade results in improved tumor control.